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A b s t r a c t  
The development of injectable microspheres for controlled drug delivery to the desired site is a 
major challenge. We demonstrated the possibility of entrapping an anticancer drug, Imatinib 
mesylate, in collagen coated biodegradable poly (lactic acid) microspheres with a mean diameter of 
10-20 øm. The collagen coating on polymeric matrix surfaces through various surface modification 
techniques was the current scenario to improve bio-integration of the polymers with the in-vivo 
system. Here protein adsorption principle is used and various characterization techniques like FTIR, 
DSC and SEM analysis are used to confirm collagen coating. The reduction in burst release of the 
Imatinib from the PLA microspheres further confirms its presence and role in controlled release.  
This collagen coated PLA microspheres may have potential for the targeted delivery of Imatinib 
mesylate to treat gastrointestinal stromal tumors, chronic myeloid leukemia cancer. 
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Introduction 
Poly (lactic acid) and its derivatives, with their outstanding 
biocompatibility and biodegradability have become increasingly 
important in the development of drug delivery matrices and their 
use in biomedical applications [1-3]. Among different dosage forms 
reported, PLA microspheres have been identified as a noble class 
of matrices possessing a great potential as drug carriers. 
Administration of drugs via such systems is advantageous because 
microspheres can be ingested or injected and they can be tailored 
for desired release profiles and used for site-specific delivery and 
in some cases can even provide organ-target release [4]. 
(Freiberg, 2004). In recent years, PLA microspheres have gained 
much attention in selective localized drug delivery systems for 
tumor therapies without surgical intervention in the tumor-removed 
sites [5-7].  
Imatinib Mesylate specifically inhibits enzyme ÂÂtyrosine kinase 
receptorÊÊ that is characteristic of a particular cancer cell, rather 
than non-specifically inhibiting and killing all rapidly dividing cell. 
Tyrosine kinases are proteins used to signal to each other to grow. 
They act as chemical messengers. There are number of different 
tyrosine kinases. Imatinib blocks the particular protein kinases and 
stops the growth of cancer cells. Imatinib Mesylate has been 
selected as a model drug used for treatment of brain tumor, in 
particular GIST, CML cancer [8, 9]. (David, 1997; Jabbour, 2007). 
Controlled, biocompatible and biodegradable as well as local drug 
delivery systems are to be developed to achieve therapeutic 
concentration at the diseased /cancerous site for prolonged period. 
PLA is widely used biodegradable polyester for the development of 
long-term drug delivery carriers such as cell microcarrier/scaffold in 
tissue engineering applications [10]. Though PLA has many 
advantages such as biodegradability, biocompatibility and non-
toxicity, a surface modification (coating) is still required to further 
improve its cytocompatibility, because PLA is rather hydrophobic 
and lack in cell adhesion site [11].  
Natural biomacromolecules such as collagen have domains in their 
molecules recognized as ligands that can specifically bind with 
integrin on cell membranes, thus can effectively accelerate cell 
attachment and spread. Presently collagen coating is a prime step 
in tissue engineering and drug delivery devices to mimic and 
enhance compatibility of synthetic polymers such as PLA. Recently 
collagen coating has to be done on polymeric scaffold surfaces 
through various surface modification techniques such as covalent 
bonding [12], layer-by-layer assembly [13],  grafting-coating [14] 
and adsorption [15]  to anchor biomacromolecules on to synthetic 
material surfaces. Among them adsorption is a widely used surface 
phenomenon in various industrial applications. Protein adsorption 
is the earliest event on the surface of drug carrier to provide cell 
adhesion and proliferation. This clearly reveals the importance of 
surface characteristics of microcarriers and their role as imperative 
mediator for biological response.  
In continuation of our polymeric drug release studies [16, 17] our 
present research work is exploring the possibility of simple 
adsorption phenomenon to coat polymeric micro particulates with 
collagen for improving compatibility of imatinib loaded PLA 
microspheres and its effect in drug release. 
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Poly (Lactic Acid) (Aldrich chemicals (St. Louis) USA), Gelatin and 
Collagen were supplied by Sigma (Sigma-Aldrich, Milwauka, USA). 
Imatinib drug was received as a gift sample from CIPLA pharma, 
Bangalore, India. All chemicals were AnalaR grade and were used 
as received. Throughout the experiment double-distilled water was 
used.  
Preparation of Collagen coated Poly Lactic acidă
Imatinib microspheres 
Imatinib mesylate loaded poly (lactic acid) (PLA-IM) microspheres 
were successfully prepared using W/O/W double emulsion solvent 
evaporation method using gelatin as stabilizer. Briefly 0.5 g of PLA 
was dissolved in 3 ml of methylene chloride (DCM). Into this 
organic phase (O), 250 øl of aqueous drug solution (W1) was 
emulsified to form W1/O emulsion. The primary emulsion was 
slowly added drop wise into 500 ml of 0.5% aqueous gelatin 
solution (W2) and homogenized for 5 min at 1000 rpm. The 
resulting W1/O/W2 emulsion was kept under mechanical stirring 
until complete evaporation of the solvent.  Microspheres were 
recovered by filtration and dried at room temperature. The 
completely dried PLA-IM microspheres (50mg) were added to 
3mg/ml concentration of collagen containing centrifuge (15ml) 
tubes and kept at 6000 rpm for 10 min. to decant supernatant. The 
collagen coated PLA-IM microspheres were washed with distilled 
water and dried at room temperature and collected for further 
characterization. 
Characterization Techniques 
Fourier Transform Infrared Spectroscopy (FTIR) studies 
PLA-IM microspheres and Collagen coated PLA-IM microspheres 
were recorded „between‰ 400-4000 cm-1 using an ATR-FTIR 
spectroscopy (ABB MB3000, ABB Bomen Inc., Canada). 
Differential Scanning Calorimetry (DSC) studies 
Differential scanning calorimetry (DSC) measurements were 
performed using SDT-Q600 thermal system. Weighed samples of 
10 mg were placed in alluminium pans under nitrogen at a flow rate 
of 20 mL/min. the samples were heated from 30 to 8000 C at a rate 
of 100 C/min. 
X-Ray Diffraction (XRD) studies  
Powder X-Ray diffraction (PXRD) measurements were performed 
on a Siemens D 5000 (Germany). The powder was placed on the 
glass sample folder, and measurements were performed using a 
copper target at 40 mA with a scanning speed of 100/min and a 2θ 
range of 0-900. 
Scanning electron microscopy (SEM) studies 
Un-Coated and Collagen-Coated PLA-IM microspheres were 
analyzed by a scanning electron microscope (JEOL JSM 840 A 
SEM, Japan) to confirm the presence of collagen on the surface of 
the PLA-IM microspheres. 
In vitro release studies  
In vitro release studies were performed at 370 C using the Tablet 
dissolution tester (Lab India, Mumbai, India) equipped with six 
paddles at a paddle speed of 100 rpm. About 50 mL of phosphate 
buffer solution (pH=7.4) was used as the dissolution media. The 
sample was sealed in a dialysis bag, which was suspended in a 
sealed beaker containing release medium at constant stirring. At a 
fixed time intervals, 2 mL of the resultant release medium was 
sampled for the analysis of Imatinib content, then 2 mL of the fresh 
release medium was immediately added to maintain the original 
volume. The amount of Imatinib released was analyzed based on 
the standard curve using a UV Spectrophotometer at the λmax of 
236 nm. The cumulative amount of drug released into the media at 
each time point was evaluated as the percentage of total drug 
release to the initial amount of the drug. 
Results and Discussion 
Entrapment Efficiency 
The entrapment efficiency was determined by the following 
procedure [18]. (Natarajan, 2011). Briefly 10 mg microspheres 
were dissolved in 200 øl of DCM, from this 2 ml of it taken in 
appendorf tubes and vortexed for 10 min. 1800 øl of ethanol was 
added to precipitate the polymer as well as to extract the drug to 
ethanol. After centrifuging for a period of 20 minutes at the rate of 
2500 rpm, the 200 ml of supernatant was suitably diluted and 
detected the wave length using UV spectrophotometry. The 
entrapment efficiency of Imatinib onto the PLA-IM microspheres 
was found to be 64.24μ0.55% whereas in collagen coated PLA-IM 
microspheres it was 59.42%. The result indicates the 5% Imatinib 
loss in the collagen coating process.  
FTIR analysis 
Figure. 1 shows the FTIR spectrum of pure Imatinib mesylate drug 
and Figure. 2 shows the FTIR spectrum of uncoated (Figure. 2a) 
and collagen coated (Figure. 2b) microspheres. From Figure. 1 it is 
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Figure 1. FTIR spectra of pure Imatinib mesylate drug 
 
The FTIR spectrum of PLA-IM (Figure. 2a) microspheres having a 
strong and broad shoulder peak in the region of 3650-3050 cm-1 
correlates the stretching of multiple O-H and N-H groups of PLA 
and Imatinib respectively. The C-H stretching adjacent to aromatic 
ring of Imatinib was observed to be overlapped with the N-H 
stretching of Imatinib. The aromatic C=C stretching of Imatinib was 
observed at 1527 cm-1. The stretching of C=O of PLA was 
observed at the frequency of 1658 cm-1 where as the lower 
characteristic C=O stretching of amide of Imatinib was observed at 
the 1607 cm-1 due to the presence of inter molecular H-bonding.  
 
Figure 2. FTIR spectra of uncoated (a) and collagen coated (b) drug loaded PLA  microspheres. 
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The collagen coated microspheres (Figure. 2b) have the similar 
trend of peaks as that of PLAăImatinib microspheres with a few 
exceptions. The presence of amide A functionality in collagen 
showed an increment in the intensity of the broad peak area at the 
frequency range of 3650-3050 cm-1. After the intense sharp peaks 
for stretching of C=O of PLA, there were two peaks, one at 1650 
cm-1 that represents the main C=O stretching of amide I, followed 
by the second incompletely resolved shoulder peak at 1534 cm-1 
which was for the amide II group of the collagen molecule. The 
presence of these two amide peaks (absent in the PLA-Imatinib 
spectrum) clearly shows the presence of surface layer of collagen 
on the solid particles. The three peaks at 1365, 1292 and 1238 cm-
1 for collagen coated microspheres in the spectral region of 1200-
1400 cm-1 are attributed to the CN stretching coupled with NH 
bending from amide III.  
Differential scanning calorimetric studies 
 
Figure 3. DSC thermograms of pure drug (a), drug loaded PLA microspheres (b) and 
collagen coated PLA microspheres (c). 
 
The onset melting point of imatinib was observed at 230o C from 
Fig. 3a. However, no characteristic peak of imatinib was observed 
in the DSC curves of the un-coated PLA-imatinib microspheres 
(Figure. 3b) and collagen coated PLA-imatinib microspheres 
(Figure. 3c). Absence of the drug melting peak in DSC thermogram 
of uncoated and collagen coated PLA-imatinib microspheres is a 
sign of molecularly dispersed drug within the polymer matrix. 
X-Ray diffraction studies 
The diffraction pattern of Imatinib exhibits many diffraction peaks 
(Figure. 4a), revealing its crystalline state. The diffraction pattern of 
Imatinib loaded PLA microspheres (Figure. 4b) shows the broad 
and intense diffraction peak, which was centered at 16.25o and 
could be assigned to PLA. This suggests that Imatinib was 
molecularly dispersed in PLA  
microspheres. The diffraction pattern of collagen coated PLA 
microspheres (Figure. 4c) shows no evident diffraction peaks, 
which denotes confirmation of collagen coating on PLA 
microspheres. 
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Figure 4. PXRD patterns of pure drug (a), drug loaded PLA microspheres (b) and collagen 
coated PLA microspheres (c). 
 
Scanning electron microscopic studies 
The PLA-Imatinib microspheres (Figure 5a) are spherical with 
uniform surface without forming agglomeration. The SEM images 
of collagen coated PLA-Lapatinib microspheres (Figure 5b) clearly 
shows a distinct coating compared to the SEM images of PLA-
Imatinib microspheres. The coating of collagen was observed 
through adsorption over the surface of the microspheres. The SEM 
images also show that the collagen adsorbed has covered all the 
surface of the particles including the adhered particles protruded 
on the surface. The complete coating on the surface through 
adsorption may give an enhanced effect on improving the bio-
compatibility or bio-integration of the microspheres. 
 
Figure 5. Scanning electron micrographs of uncoated (a) and collagen coated (b) microspheres. 
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 In vitro release studies 
 
Figure 6. % Cumulative release of Imatinib through coated and uncoated PLA microspheres 
 
The release profile of Imatinib mesylate through PLA-based 
microspheres was studied in phosphate buffer (pH 7.4) at 370 C for 
30-35 days and found to be effected by collagen coating. Coated 
and uncoated microspheres showed a initial burst release of 12 
and 18 respectively, in the first day of release and the drug release 
continued steadily thereafter. The release rate of Imatinib from 
coated microspheres was significantly slower than uncoated 
microspheres. In un-coated microspheres, the release of the drug 
was almost complete by 35 days, while it was 76% for coated 
microspheres. The results show that collagen coated through 
adsorption may be advantageous in controlling situations like 
Imatinib release and burst effect, which may sometimes be toxic to 
the site if the dose overcomes maximum therapeutics 
concentration. 
Conclusions 
The development of simple method to coat the extra cellular matrix 
protein-collagen on solid surface of micro-particulate implants 
through adsorption phenomena and its confirmation through FTIR, 
SEM analysis and gives novel method for the development of 
stealth micro/nano injectables as well as implants in the field of 
targeted and localized drug delivery systems. The study has to be 
extended to understand the physiochemical mechanisms and bio-
integration advantages of this type of carriers in the drug delivery 
as well as in tissue engineering.  
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